A True Ground Floor Legal Marijuana Opportunity Now Open

A True Ground Floor Legal Marijuana Opportunity Now Open
A True Ground Floor Legal Marijuana Opportunity Now Open

HOW CANNABIS COULD DISRUPT THE PHARMACEUTICAL INDUSTRY 

 

  • An Innovative Company Combines Professional Medicine AND Natural Healing Properties Of Marijuana

  • The marijuana boom is powering an entirely new segment of the industry in 2018…

  • The time to get in on the ground floor is right now.


Dear Seed Investor,
 
There are even dozens of publicly traded pot stocks. But should you buy any of them? Probably not...Unless you don't mind seeing your portfolio do a Cheech and Chong and go up in smoke. 
 
That’s the advice CNN Money mockingly dispensed three years ago.
 
At the time it was the widely-held position.
 
It was also about the same time the Seed Investor was founded to help guide investors to capitalize on the best marijuana stocks around.
 
Naturally, the warning to steer clear of marijuana stocks couldn’t have been more wrong.
 
Anyone who listened to these and countless other “experts” would have missed out on the greatest investment opportunity in years.
 
Not to worry though. Legal barriers are falling around the world. Canada just fully legalized marijuana a few days ago. Germany has taken steps to legalizing it. And more states are set to join in in November’s elections.
 
The marijuana boom is still in the early stages and, as it grows, it’s going to create some opportunities for those investors paying close attention.
 
One of those specific opportunities in marijuana is still in the earliest of stages.
 
And as you’ll see below, one fast-growing, uniquely positioned marijuana company is at the forefront of the next big opportunity in marijuana.
 
Check this out.
 
While they’re playing catch up, the Seed Investor is making its next move and has identified a new stock that is looking like it’s set to ride the next wave in marijuana stocks.
 

The Next Leg Of the Marijuana Boom Starts Right Here

 
Marijuana stocks have been on a massive run ever since CNN and others advised to avoid the sector.
 
The Seed Investor has been, admittedly, a bit more tactical than many others when it comes to the marijuana sector.
 
We’ve prided ourselves on predicting each specific progression in the long marijuana boom up until now.
 
We’ve featured a number of companies including marijuana-based biotech, marijuana growth and production, and retail marijuana in anticipation of Canada’s marijuana legalization.
 
It has paid off each time too.
 
Now, we’re getting positioned for the next leg of the marijuana boom.
 
That is legitimate, professionally prescribed medicinal marijuana.
 
We’re not talking about some stereotype of a tie-dyed shirt wearing hippie recommending this or that strain of marijuana.
 
No. We’re talking about medical professionals designing a treatment plan around the medicinal benefits of marijuana and prescribing it to patients in a medical office setting.
 
This is the real deal.
 

How Medicinal Marijuana Goes Mainstream

 
Perhaps the greatest opportunity in all of marijuana is in medicinal marijuana.
 
Yes, the retail and recreational use marijuana markets are worth billions of dollars today and climbing towards tens of billions of dollars.
 
However, the medicinal benefits of marijuana have an even greater market potential to take a chunk of.
 
It’s simple numbers.
 
Marijuana has been used for centuries for its natural healing properties.
 
Now, it’s been viewed as an illegal and mainly recreational drug for so long though, it’s medicinal properties are so much forgotten even though they may prove to be the most valuable part of the marijuana in the long run.
 
Consider this.
 
GW Pharmaceuticals (GWPH) has developed Epidiolex, a drug used for treating epilepsy, by extracting the medicinal elements of a the marijuana plant and turning them into a pharmaceutical grade prescription drug.
 
The drug has been approved for prescription in many countries around the world and it could be approved for use in the U.S. as soon as next year.
 
The success of Epidiolex has propelled GW Pharmaceuticals’ shares from $9 to more than $150 over the last five years.

 
 

And that’s just one example.

Medicinal marijuana has been used effectively to treat many common conditions.
 
 
That’s the potential market for treatment-focused medicinal marijuana.
 
As the marijuana industry matures, you can bet these people who suffer from these will seek out medicinal marijuana.
 
That’s where a small company named Empower Clinics (CDN:EPW; USA:ADENF).
 
Empower Clinics is a newly-listed public company focused on providing medical industry quality services to the patients turning to the medicinal benefits of marijuana as a treatment for their conditions.
 
Empower Clinics has three fully-staffed medical clinics in Oregon, another one in Washington, and one in Chicago, Illinois. It also has an additional 10 satellite clinics throughout Washington and Oregon.

 

 
 
Each of these clinics looks just like a regular medical office and is staffed by a fully-licensed medical doctor (M.D.).
 
These are not corner pot shops. They look and operate just like medical clinics you’ll find anywhere else in the country.
 
If you want to see where one major untapped source of marijuana growth is just getting started, the high-end medicinal use marijuana side and Empower Clinics (CDN:EPW; USA:ADENF is a great place to start.
 

Bigger Than You Think: The Future Of Marijuana Industry

 
The marijuana industry is on the growth path to becoming a truly major industry.
 
In Canada the marijuana industry annual revenues are on pace to eclipse both beer and wine sales as early as 2022.
 
The U.S. is not far behind.
 
Although the U.S. political system is not as fast as Canada’s, you can miss what’s happening all around the country.
 
Washington and Colorado were early movers into legalizing marijuana usage.
 
Just a few short years later their legal marijuana industries are raking in billions of dollars in sales each year and still growing.
 
California, Nevada, and other states which recently fully legalized marijuana are on the same trajectory.
 
The medicinal marijuana side is just as exciting.
 
Dozens more states have made an exception by legalizing marijuana usage for medicinal purposes only.
 
The early numbers in these states show there’s a massive opportunity here too.
 
In Florida alone more than 100,000 medicinal marijuana patients have already received medicinal marijuana licenses and

are taking advantage of the medicinal benefits of this natural therapy.

At this point, even those at CNN Money and the mainstream financial media can’t deny the legal marijuana industry has years and years of massive growth ahead of it.
 



 
 
There will be many opportunities along the way.

The way the industry is headed right now, the companies with a high degree of professionalism like Empower Clinics (CDN:EPW; USA:ADENF) are going to ride the wave for a long time to come even though it’s still a ground-floor growth company at this time.
 
Best regards,
 
 
The Seed Investor

------------------------------------------------


Please see full disclaimers at www.TheSeedInvestor.com applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimer.

Disclaimer: This release/advertorial is a commercial advertisement and is for general information purposes only. This release/advertorial does not constitute an offer or solicitation to buy or sell any securities or individualized investment advice. This is a native advertisement, meaning it is an informational paid marketing piece. THESEEDINVESTOR.com (TSI) makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. TSI receives payments ranging from approximately $25,000 to $150,000 to publish and/or distribute advertisements on behalf of a company. TSI retains any excess sums after expenses as its compensation. TheSeedInvestor.com and its owners, operators and affiliates may benefit from any increase in the share prices of the profiled companies. TheSeedInvestor.com may be paid for services using options or free-trading shares. TheSeedInvestor.com and/or its owners, operators and affiliates may be selling shares of stock at the same time the profile (or other information) is being disseminated to potential investors; TheSeedInvestor.com will not advise when it or its affiliates decide to sell. Investors must make all investment decisions based on their own judgment of the market and the particular securities.
This advertorial contains forward-looking statements that involve risks and uncertainties. This advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to plans and strategies of the featured company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe(s),” “anticipate(s),” “plan(s),” “expect(s),” “project(s),” “will,” “make,” “told,” “could,” “might,” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the company to differ materially from these indicated by such forward-looking statements. Certain statements contained herein are forward-looking statements as defined in Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business, financing, business trends, future operating revenues and expenses. There can be no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the company, or contained in this advertorial are not guarantees of future performance, and that the issuer’s actual results may differ materially from those set forth in the forward-looking statements. We undertake no obligation to update any statements made herein except as required by law. Differences in results can be caused by various factors including, but not limited to, the company’s ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. To reiterate, information presented in this advertorial contains “forward-looking statements.” Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. More information on the company may be found at http://www.sec.gov where readers can review all public filings submitted by the company. TheSeedInvestor.com is not a certified financial analyst or licensed in the securities industry in any manner. The information in this advertorial is subjective opinion and may not be complete, accurate or current and was paid for, so this could create a conflict of interest.
 

 
 
 

 

CBD Beverage Stocks Are Pouring Investor Profits

Click Here For Free Report

Please see full disclaimers at www.TheSeedInvestor.com applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimer

Disclaimer: This release/advertorial is a commercial advertisement and is for general information purposes only. This release/advertorial does not constitute an offer or solicitation to buy or sell any securities or individualized investment advice. This is a native advertisement, meaning it is an informational paid marketing piece. THESEEDINVESTOR.com (TSI) makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. TSI receives payments ranging from approximately $25,000 to $150,000 to publish and/or distribute advertisements on behalf of a company. TSI retains any excess sums after expenses as its compensation. TheSeedInvestor.com and its owners, operators and affiliates may benefit from any increase in the share prices of the profiled companies. TheSeedInvestor.com may be paid for services using options or free-trading shares. TheSeedInvestor.com and/or its owners, operators and affiliates may be selling shares of stock at the same time the profile (or other information) is being disseminated to potential investors; TheSeedInvestor.com will not advise when it or its affiliates decide to sell. Investors must make all investment decisions based on their own judgment of the market and the particular securities.

This advertorial contains forward-looking statements that involve risks and uncertainties. This advertorial contains or incorporates by reference forward-looking statements, including certain